The AAFP has reviewed Tick-borne Diseases, and deemed it acceptable for AAFP credit. Term of approval is from 02/14/2024 to 02/12/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This session, Early Lyme Disease, is approved for 1.25 Prescribed credits.
Learning objectives
Lyme disease is an increasingly common infectious disease in many regions of the U.S. Prompt diagnosis and treatment of early Lyme disease results in better outcomes. This presentation provides physicians with clinically relevant information that will enhance their diagnostic and management skills.
After completing this module, learners should be able to:
- Describe epidemiologic risk factors
- Recognize various disease presentations
- Summarize the EM trial evidence
- Explain treatment options and the clinical factors influencing management decisions